Market Cap 22.18M
Revenue (ttm) 340,000.00
Net Income (ttm) -39.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11,588.24%
Debt to Equity Ratio -0.52
Volume 57,000
Avg Vol 51,066
Day's Range N/A - N/A
Shares Out 8.60M
Stochastic %K 25%
Beta 0.46
Analysts Strong Sell
Price Target $45.17

Latest News on CLNN

Clene to Present at the 37TH Annual Roth Conference

Mar 6, 2025, 8:30 AM EST - 27 days ago

Clene to Present at the 37TH Annual Roth Conference


Clene to Present at the Emerging Growth Conference

Jul 12, 2024, 10:34 AM EDT - 9 months ago

Clene to Present at the Emerging Growth Conference


Clene Announces 1-for-20 Reverse Stock Split

Jul 9, 2024, 8:00 AM EDT - 9 months ago

Clene Announces 1-for-20 Reverse Stock Split


Clene to Present at Upcoming May Conferences

May 14, 2024, 8:00 AM EDT - 11 months ago

Clene to Present at Upcoming May Conferences


Clene to Present at Upcoming September Conferences

Aug 30, 2023, 8:20 AM EDT - 1 year ago

Clene to Present at Upcoming September Conferences


Clene Announces Pricing of $40 Million Public Offering

Jun 16, 2023, 8:00 AM EDT - 1 year ago

Clene Announces Pricing of $40 Million Public Offering


Clene Announces Launch of Proposed Public Offering

Jun 15, 2023, 4:38 PM EDT - 1 year ago

Clene Announces Launch of Proposed Public Offering


Clene Appoints Neurology Expert to Executive Team

Mar 16, 2023, 9:46 AM EDT - 2 years ago

Clene Appoints Neurology Expert to Executive Team